Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Pharmacodynamic Studies of Methylphenidate Extended Release Products in Pediatric Attention Deficit Hyperactivity Disorder

NCT02536105 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02536105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02536105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Pharmacodynamic Studies of Methylphenidate Extended Release Products in Pediatric Attention Deficit Hyperactivity Disorder
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2016
Completion date
July 31, 2018
Enrollment
88 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder